{"id":"https://openalex.org/W2114155672","doi":"https://doi.org/10.1016/j.jalz.2013.11.008","title":"Adverse events and dropouts in Alzheimer's disease studies: What can we learn?","display_name":"Adverse events and dropouts in Alzheimer's disease studies: What can we learn?","publication_year":2014,"publication_date":"2014-03-07","ids":{"openalex":"https://openalex.org/W2114155672","doi":"https://doi.org/10.1016/j.jalz.2013.11.008","mag":"2114155672","pmid":"https://pubmed.ncbi.nlm.nih.gov/24613705"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2013.11.008","doi":"https://doi.org/10.1016/j.jalz.2013.11.008","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2013.11.008","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103227440","display_name":"David B. Henley","orcid":"https://orcid.org/0009-0009-6698-750X","observed_orcids":["https://orcid.org/0009-0009-6698-750X"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David B. Henley","raw_affiliation_strings":["Lilly Research Laboratories, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105691065","display_name":"Karen L. Sundell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen L. Sundell","raw_affiliation_strings":["Lilly Research Laboratories, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109144493","display_name":"Gopalan Sethuraman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gopalan Sethuraman","raw_affiliation_strings":["Lilly Research Laboratories, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059020389","display_name":"Lon S. S. Schneider","orcid":"https://orcid.org/0000-0002-4636-6150","observed_orcids":["https://orcid.org/0000-0002-4636-6150"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lon S. Schneider","raw_affiliation_strings":["Department of Psychiatry and the Behavioral Sciences and Department of Neurology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and the Behavioral Sciences and Department of Neurology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I1174212"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5103227440"],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":0.6228,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.70269972,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"11","issue":"1","first_page":"24","last_page":"31"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.6161999702453613,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.6161999702453613,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.3522999882698059,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.012299999594688416,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9959999918937683},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8159999847412109}],"concepts":[{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8770630359649658},{"id":"https://openalex.org/C119060515","wikidata":"https://www.wikidata.org/wiki/Q1916617","display_name":"Interquartile range","level":2,"score":0.8736267685890198},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8255928754806519},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7844387292861938},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6492257714271545},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5323052406311035},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.49023276567459106},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43689629435539246},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4125065803527832},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.07716357707977295},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000058","descriptor_name":"Accidental Falls","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000409","descriptor_name":"Alanine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000409","descriptor_name":"Alanine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001281","descriptor_name":"Atrial Fibrillation","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010352","descriptor_name":"Patient Dropouts","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011014","descriptor_name":"Pneumonia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059906","descriptor_name":"Neuroimaging","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jalz.2013.11.008","doi":"https://doi.org/10.1016/j.jalz.2013.11.008","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2013.11.008","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"},{"id":"pmid:24613705","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24613705","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & dementia : the journal of the Alzheimer's Association","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307920","display_name":"Baxter International","ror":"https://ror.org/02d6ew870"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W613953456","https://openalex.org/W1963633112","https://openalex.org/W1982816514","https://openalex.org/W2030025114","https://openalex.org/W2039140744","https://openalex.org/W2047089318","https://openalex.org/W2086572083","https://openalex.org/W2112150247","https://openalex.org/W2118096545","https://openalex.org/W2119062449","https://openalex.org/W2122867853","https://openalex.org/W2138904731","https://openalex.org/W2144356782","https://openalex.org/W2147937910","https://openalex.org/W2156220037","https://openalex.org/W2165136235","https://openalex.org/W2488375007","https://openalex.org/W2801372471","https://openalex.org/W2977025277"],"related_works":["https://openalex.org/W2144356782","https://openalex.org/W2052507724","https://openalex.org/W4206800149","https://openalex.org/W2115467663","https://openalex.org/W2038555561","https://openalex.org/W4400094143","https://openalex.org/W4392190666","https://openalex.org/W4406224540","https://openalex.org/W4205287372","https://openalex.org/W2000232222"],"abstract_inverted_index":{"BACKGROUND:":[0],"Interpreting":[1],"Alzheimer's":[2],"disease":[3],"(AD)":[4],"clinical":[5,36],"trial":[6],"(CT)":[7],"outcomes":[8],"is":[9],"complicated":[10],"by":[11,71,135],"treatment":[12],"dropouts":[13],"and":[14,24,40,54,68,73,88,117,127,131,137,142,171,179],"adverse":[15,114],"events":[16,115],"(AEs).":[17],"In":[18],"elderly":[19],"participants,":[20],"AE":[21,130],"rates,":[22],"dropouts,":[23],"deaths":[25,118],"are":[26,43,172],"important":[27],"considerations":[28],"as":[29],"they":[30],"may":[31],"undermine":[32],"the":[33,150,163],"validity":[34],"of":[35,165],"trials.":[37],"Published":[38],"discontinuation":[39,132],"safety":[41,158],"data":[42,47,159],"limited.":[44],"METHODS:":[45],"Safety":[46],"from":[48],"1054":[49],"placebo-treated":[50],"participants":[51],"in":[52,62,149,174,180],"IDENTITY":[53],"IDENTITY-2,":[55],"76-week,":[56],"Phase":[57],"3":[58],"AD":[59],"studies":[60],"conducted":[61],"31":[63],"countries,":[64],"were":[65,86,119,146],"pooled,":[66],"annualized,":[67],"summarized":[69],"overall,":[70],"country":[72,136],"age":[74,78,138,152],"group.":[75,153],"RESULTS:":[76],"Median":[77],"was":[79,92,102],"74.2":[80],"(interquartile":[81,94],"range":[82,95],"67.9-79.5)":[83],"years;":[84],"57.4%":[85],"female;":[87],"median":[89],"observation":[90],"time":[91],"63.2":[93],"41.6-77.4)":[96],"weeks":[97],"when":[98],"study":[99],"drug":[100],"dosing":[101],"halted.":[103],"Overall":[104],"annualized":[105,156],"rates":[106,133],"for":[107],"discontinuations,":[108],"discontinuations":[109],"due":[110],"to":[111],"AEs,":[112],"serious":[113],"(SAEs),":[116],"21.6%":[120],"(range":[121,124],"19.6%-24.0%),":[122],"8.2%":[123],"8.1%-8.3%),":[125],"12.0%,":[126],"1.7%,":[128],"respectively.":[129],"varied":[134],"groups.":[139],"Fall,":[140],"pneumonia,":[141],"atrial":[143],"fibrillation":[144],"AEs":[145],"more":[147],"frequent":[148],"oldest":[151],"CONCLUSIONS:":[154],"These":[155],"placebo":[157],"provide":[160],"insight":[161],"into":[162],"course":[164],"enrolled":[166],"patients":[167],"with":[168],"mild-to-moderate":[169],"AD,":[170],"useful":[173],"planning":[175],"longer":[176],"term":[177],"trials":[178],"monitoring":[181],"safety.":[182]},"counts_by_year":[{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}